At TCG Labs-Soleil, we are establishing a pioneering venture-biotech model in collaboration with The Column Group. Our mission is to efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.

Venture Capital

Life Sciences

Health Care

Biotechnology

TCG Labs-Soleil

Jin-Long Chen

Harding L.

Kathy Miller

Sarah Hymowitz

Lucinda Quan

Josh Lichtman

Hui Tian

Corinne Foo - Atkins

Harding Luan

Tim Kutzkey

The Research and Development team at TCG Labs-Soleil focuses on bridging scientific discovery and clinical application. They work on generating innovative biologic therapies from the ground up, leveraging the combined strengths of top scientists and dedicated research associates. This team drives projects from initial concept through to clinical proof of concept, ensuring that promising therapeutic candidates are primed for strategic partnerships and transformative impact in treating serious diseases.

Research and Development

Leadership Team

Academic and Science Team

��

Research and Development

About

Team members

Other teams at TCG Labs-Soleil

Leadership Team

Academic and Science Team

��������

Research and Development

About

Team members

Other teams at TCG Labs-Soleil

Leadership Team

Academic and Science Team

��